Viatris Pharma GmbH - Lenalidomid Viatris 7.5 mg, Hartkapseln | | 68557 | | 03 | | Lenalidomid Viatris 7.5 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 04.04.2022 | | |
| Composition | lenalidomidum 7.5 mg, amylum pregelificatum, cellulosum microcristallinum, carmellosum natricum conexum, silica colloidalis anhydrica, natrii stearylis fumaras, Kapselhülle: E 172 (flavum), titanii dioxidum, E 172 (nigrum), gelatina, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.506 mg. | Packungsbestandteile | | Capsules | | | | | | Principe actif | Concentr. |
---|
Lenalidomidum | 7.5 mg |
| BAG: Principe actif | Concentr. |
---|
Lenalidomidum | 7.5 mg |
| | Agents auxilliaires | | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | Amylum Pregelificatum | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 172 | | color. | Gelatina | | | Kalii Hydroxidum | | | Lacca | | Drucktinte | Natrii Stearylis Fumaras | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | | Titanium Dioxide | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
003 | 21 | 726.28 | 806.30 | A | LS | Oui |
|
|